Nimesulide

This classification denotes a cyclooxygenase inhibitor with the molecular formula C13H12N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4TKW1454M, chemically known as methanesulfonanilide, 4-nitro-2-phenoxy- but generally known as nimesulide, which bears US NIH Compound Identifier 4495. European Medicines Agency schedules Nimesulide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09294MIG. The term NIMESULIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules nimesulide in its Anatomical Therapeutic Chemical (ATC) Classification. NIMESULIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nimesulide under HS 29350090 and SITC 51580. As of Q4 2014, NIMESULIDE remains the US FDA Preferred Term for this commodity. Nimesulide bears US NLM identifiers UMLS ID C0132515 and NCI Concept Code C29842. SMILES: S(=O)(=O)(NC1C(OC2CCCCC2)CC([N](=O)O)CC1)C.